Maricann Group (CSE:MARI)
(CSE:MARI.CN) (CNSX:MARI) Announces Acquisition of NanoLeaf Technologies Inc.,
Appoints New President and Chief Operating Officer
TORONTO, ONTARIO - August 22, 2017 (Investorideas.com
Newswire) Maricann Group Inc. (CSE:MARI) (CSE:MARI.CN) (CNSX:MARI)
("Maricann" or the "Company") announced today that it has
entered into an agreement ("Acquisition Agreement") to acquire 100%
of the issued and outstanding shares of NanoLeaf Technologies Inc.
("NanoLeaf"), a biotech company possessing licensing rights to a
number of globally patented technologies that provide proven pharmaceutical,
nutraceutical, cosmetic and functional beverage drug delivery formulations. The
transaction is expected to be completed by the end of September 2017.
NanoLeaf, through its licensing agreement with
Vesifact, has developed and marketed the first cannabinoid standardized dose
soft gel capsule in a nano-dispersed drug called Vesisorb. The challenge the
cannabis industry has faced is finding a predictable delivery mechanism of
cannabinoids in an oral dosing format. Cannabinoids are a fat-soluble compound
that have low solubility, leading to low dissolution rates and significant
first-pass liver metabolism resulting in low and unpredictable oral cannabinoid
bioavailability. This poor solubility not only gives low oral bio-availability
but also leads to high inter- and intra-subject variability and lack of dose
proportionality.
Read this
news in full at http://www.investorideas.com/news/2017/marijuana/08222Maricann.asp
Marijuana
/ Hemp Stocks
Like
Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Join our
Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing
Watch the 420 Cannabis Investor video
This news is published on the Investorideas.com
Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital
publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Original
content created by investorideas is protected by copyright laws other than
syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC
Residents and global Investors: Effective September 15 2008 - all BC investors
should review all OTC and Pink sheet listed companies for adherence in new
disclosure filings and filing appropriate documents with Sedar. Read for more
info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
